Catalyst Wire Dossier Catalyst Wire Dossier

Narazaciclib (ON 123300)

narazaciclib · Traws Pharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Narazaciclib (ON 123300), covering 2023-12-12 to 2023-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies [Phase 1, Phase 2]

See pricing